NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Revelation Biosciences, Inc. Common Stock Share Price Chart

O H L

Revelation Biosciences, Inc. Common Stock Performance Overview

Days Range
$0.94Low
$0.94High

Markets Today

Previous Close$0.95
Open$0.94
Volume15,623
Day's Range$0.94 - $0.94
52W Range$0.88 - $6.76
Market Cap$3.66 M

Historical Performance

1M Returns-17.12
3M Returns-6.12
6M Returns-24.59
1Y Returns-85.26
5Y ReturnsNA
10Y ReturnsNA

Revelation Biosciences, Inc. Common Stock Fundamentals

Market Cap$3.66 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.19
EPS TTM$-12.29
Quarterly Earnings Growth YOYN/A
PB Ratio0.36
EBITDA$-9.04 M
Profit MarginN/A
Market Cap$3.66 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-2.19
EPS TTM$-12.29
Quarterly Earnings Growth YOYN/A
PB Ratio0.36
EBITDA$-9.04 M
Profit MarginN/A

Revelation Biosciences, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$2.09 M-$2.46 M-$1.94 M-$2.57 M-$3.09 M-$3.66 M
EBITDA -$2.09 M-$2.45 M-$1.94 M-$2.57 M-$3.09 M-$3.65 M
Interest Expense $0$0$0$0$0$0
Depreciation $7.22 K$7.22 K$6.76 K$5.85 K$7.20 K$8.31 K
Income Before Tax -$2.05 M-$2.44 M-$1.91 M-$2.51 M-$3.01 M-$3.32 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$2.05 M-$2.44 M-$1.91 M-$2.51 M-$3.01 M-$3.32 M
Net Profit Margin ------

Revelation Biosciences, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $964$1.53 K$3.59 K$1.58 K$3.91 K$3.91 K
Reserve & Surplus -$42.56 M-$45.00 M-$46.91 M-$49.42 M-$52.43 M-$55.75 M
Non-Current Liabilities $0$0$0$723.77 K$638.18 K$550.55 K
Current Liabilities $1.09 M$1.57 M$1.85 M$2.00 M$1.42 M$1.88 M
Total Liabilities $1.09 M$1.57 M$1.85 M$2.72 M$2.06 M$2.43 M
Fixed Assets $42.39 K$35.17 K$23.92 K$18.07 K$140.72 K$172.03 K
Current Assets $3.93 M$5.36 M$12.83 M$10.81 M$14.21 M$11.68 M
Total Assets $3.97 M$5.40 M$12.86 M$11.58 M$15.04 M$12.50 M

Revelation Biosciences, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$2.05 M-$2.44 M-$1.91 M-$2.51 M-$3.01 M-$3.32 M
Operating Cash Flow -$2.79 M-$1.92 M-$1.59 M-$1.97 M-$3.21 M-$2.56 M
Investing Cash Flow $0$0$0$0-$71.88 K-$39.63 K
Financing Cash Flow $0$3.39 M$9.12 M-$41.17 K$6.70 M-$33.80 K
Change in Cash -$2.79 M$1.47 M$7.53 M-$2.01 M$3.41 M-$2.63 M

Revelation Biosciences, Inc. Common Stock Return Calculator

The Revelation Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Revelation Biosciences, Inc. Common Stock

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

FAQs

Revelation Biosciences, Inc. Common Stock (REVB) share price as of September 18, 2026 is $0.91. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Revelation Biosciences, Inc. Common Stock (REVB) Share by opening an international trading account with Angel One.
Purchasing Revelation Biosciences, Inc. Common Stock (REVB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Revelation Biosciences, Inc. Common Stock (REVB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Revelation Biosciences, Inc. Common Stock (REVB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Revelation Biosciences, Inc. Common Stock on September 18, 2026, is $3.66 M.
Revelation Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Revelation Biosciences, Inc. Common Stock (REVB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91